Medical Technology

Hypothyrodisim Doesn't Worsen COVID-19

Key Takeaways

  • Hypothyroidism was not associated with a worse prognosis among patients with COVID-19.

  • Among patients with COVID-19, those with underlying hypothyroidism were significantly less likely to require mechanical ventilation, and hospital mortality tended to be less compared with patients with normal thyroid function.

  • Patients with COVID-19 and hypothyroidism had similar comorbidities, clinical presentations, and laboratory values compared with patients without hypothyroidism.

Why This Matters

  • This study has the largest sample of patients with COVID-19 and hypothyroidism to date.

  • The findings suggest that underlying hypothyroidism does not lead to worse outcomes in patients with COVID-19.

Study Design

  • Data were collected by the Brazilian COVID-19 Registry, which includes 37 hospitals, from 7762 patients with a confirmed diagnosis of COVID-19 during March 1 to September 30, 2020.

  • Of these patients, 526 had a clinical history of previously diagnosed hypothyroidism and were receiving levothyroxine replacement therapy at 31 of the participating hospitals in 15 Brazilian cities.

  • The researchers matched these case patients with 526 control patients who had had COVID-19 and did not have a history of hypothyroidism.

Key Results

  • Patients in the two study arms were closely matched with respect to many factors, including demographics, vital signs, comorbidities, laboratory values, and hospitalization course.

  • Mechanical ventilation was needed by 25% of patients with hypothyroidism and by 33% of those without hypothyroidism (P = .006).

  • In-hospital mortality occurred in 22% of those with hypothyroidism and in 27% of those without hypothyroidism (P = .062).

  • Average length of hospitalization was 8 days among those with hypothyroidism and 9 days among those without hypothyroidism (P = .029).


  • The study was limited by the size of the enrolled population and the number of events they experienced.

  • The study was retrospective and was limited to data extracted from chart reviews.

  • Thyroid status depended on patient-supplied information at the time of hospital admission.

  • The patients’ levels of thyroid stimulating hormone and thyroid hormone were not evaluated during hospitalization.


This is a summary of a preprint of a research article written by corresponding author Milena Soriano Marcolino, MD, PhD, from the University Hospital of the Federal University of Minas Gerais, in Belo Horizonte, Brazil, and co-authors published on MedRxiv. This study has not yet been peer reviewed. The full text of the study can be found on .

Content Source:

The Medical Progress

The Medical Progress is here to provide news for the medical industry on a daily basis which are mainly on the medical cannabis and it’s legalisation.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *